Subject:

Ondansetron   New Search


View on DBpedia    View on Wikipedia
Top related subjects:
 Chemotherapy 5-HT3 receptor Dopamine Dexamethasone Antiemetic Vomiting Palonosetron Olanzapine Metoclopramide Granisetron Ondansetron Radiation therapy Breast cancer Neoadjuvant therapy Metastasis Carcinoma Estrogen receptor Striatum Protein Serotonin Acid Tyrosine hydroxylase Multiple myeloma Phosphorylation Messenger RNA Cisplatin Syndrome Logistic regression Gastrointestinal tract Higher Education Commission of Pakistan Risperidone Antipsychotic Quetiapine Schizophrenia Haloperidol Prokinetic agent Indigestion The Tested Physiologically based pharmacokinetic modelling Pharmacokinetics
RELATED SUBJECTS:
The publications listed also have these subjects

Chemotherapy  4 times
Dopamine  3 times
Dexamethasone  3 times
Antiemetic  3 times
Vomiting  2 times
Olanzapine  2 times
Estrogen receptor  2 times
The Tested  1 time
Thalamus  1 time
Serotonin  1 time
Sedative  1 time
Racemic mixture  1 time
Polyethylene glycol  1 time
Placebo  1 time
Pharmacokinetics  1 time
Pancreas  1 time
PH  1 time
Oncology  1 time
Norepinephrine  1 time
Nifedipine  1 time
Neutrophil  1 time
Myeloperoxidase  1 time
Midazolam  1 time
Metronidazole  1 time
Metoprolol  1 time
Methanol  1 time
Methamphetamine  1 time
Messenger RNA  1 time
Lipase  1 time
Hypromellose  1 time
Hypothalamus  1 time
Hippocampus  1 time
High-performance liquid chromatography  1 time
Graph of a function  1 time
Gastroenteritis  1 time
Enzyme  1 time
Edema  1 time
Diazepam  1 time
Cytochrome P450  1 time
Confidence interval  1 time
Cisplatin  1 time
Chirality  1 time
Cerebral cortex  1 time
Cerebellum  1 time
Caffeine  1 time
Blood plasma  1 time
Biological half-life  1 time
Bioavailability  1 time
Bioactive compound  1 time
Astrocyte  1 time
Anxiolytic  1 time
Anthracycline  1 time
Amylase  1 time
Albumin  1 time
Adjuvant therapy  1 time
Acid  1 time

Publications tagged with this subject: 11

Note: Top 50 publications shown only. Open an item panel to view more info (open all)




Questions?

Drop us a message.